Role of scintigraphy in differential diagnosis of adrenal lesions

Minerva Chirurgica

Volumn 69, Issue 2 SUPPL.1, 2014, Pages 105-109

  Selvaggi, F ^a   Pellino, G ^a   Pellegrino, T ^b   Sciaudone, G ^a   Candilio, G ^a   De Fatico, G S ^a   Landino, I ^a   Canonico, S ^a   Cuocolo, A ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adrenocortical adenoma; Pituitary ACTH hypersecretion; Radionuclide imaging

Indexed keywords

EID: 84907422190     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Avram AM, Fig LM, Gross MD et al. Adrenal gland scintigraphy. Semin Nucl Med 2006;36:212-27.
2. Greco A, Petretta MP, Larobina M, Gargiulo S, Panico M, Nekolla SG et al. Reproducibility and accuracy of non-invasive measurement of infarct size in mice with high-resolution PET/CT. J Nucl Cardiol 2012;19:492-9.
3. Pellino G, Sciaudone G, Candilio G, Perna G, Santoriello A, Canonico S et al. Stepwise approach and surgery for gallbladder adenomyomatosis: a mini-review. Hepatobiliary Pancreat Dis Int 2013;12:136-42.
4. Selvaggi F, Cuocolo A, Sciaudone G, Maurea S, Giuliani A, Mainolfi C. FGD-PET in the follow-up of recurrent colorectal cancer. Colorectal Dis 2003;5:496-500.
5. Treglia G, Quartuccio N, Sadeghi R, Farchione A, Caldarella C, Bertagna F et al. Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-analysis. J Crohns Colitis 2013;7:345-54.
6. Carlomagno N, Grifasi C, Dumani X, Lo Conte D, Renda A. Clinical management of Crohn's disease in the elderly. Ann Ital Chir 2013;84:263-7.
7. Egan L, D'Inca R, Jess T, Pellino G, Carbonnel F, Bokemeyer B et al. Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II). J Crohns Colitis 2014;8:19-30.
8. Pellino G, Sciaudone G, Candilio G, Camerlingo A, Marcellinaro R, Rocco F et al. Complications and functional outcomes of restorative proctocolectomy for ulcerative colitis in the elderly. BMC Surg 2013;13(Suppl 2):S9.
9. Pellino G, Sciaudone G, Miele E, Candilio G, De Fatico GS, Riegler G et al. Functional outcomes and quality of life after restorative proctocolectomy in paediatric patients: a case-control study. Gastroenterol Res Pract 2014;2014:340341.
10. Sciaudone G, Di Stazio C, Limongelli P, Guadagni I, Pellino G, Riegler G et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg 2010;53:299-304.
11. Sciaudone G, Pellino G, Riegler G, Selvaggi F. Infliximab in drug-naïve patients with failed ileorectal anastomosis for Crohn's disease: a new chance for sparing the rectum? Eur Surg Res 2011;46:163-8.
12. Kloos RT, Gross MD, Korobkin IR et al. Incidentally discovered adrenal masses. Endocr Rev 1995;16:460-84.
13. Bombardieri E, Giammarile F, Aktolun C et al. 131I/ 123IMetaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 2010;37:2436-46.
14. Pacak K, Eisenhofer G, Ahlman H et al. Pheochromo- cytoma: recommendations for clinical practice from the first international symposium. Nature Clin Pract Endocrinol Metab 2007;3:92-102.
15. Lenders JW, Eisenhofer G, Mannelli M et al. Pheochromocytoma. Lancet 2005;366:665-75.
16. De Lellis RA, Lloyd RV, Heitz PU et al. WHO classification of tumours-pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004. p. 147-50.
17. Maurea S, Caracò C, Castelli L et al. Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity. Radiol Med 1998;95:199-207.
18. Gao B, Kong F, Xu Z et al. Development of differential diagnosis for benign and malignant pheochromocytomas. Int J Urol 2008;15:771-7.
19. Maurea S, Cuocolo A, Imbriaco M et al. Imaging characterization of benign and malignant pheochromocytoma or paraganglioma: comparison between MIBG uptake and MR signal intensity ratio. Ann Nucl Med 2012;26:670-5.
20. Maurea S, Fiumara G, Pellegrino T et al. MIBG molecular imaging for evaluating response to chemotherapy in patients with malignant pheochromocytoma: preliminary results. Cancer Imaging 2013;13:155-61.
21. Amato B, Bianco T, Compagna R, Siano M, Esposito G, Buffone G et al. Surgical resection of carotid body paragangliomas: 10 years of experience. Am J Surg 2014;207:293-2.
22. Catalano OA, Rosen BR, Sahani DV, Hahn PF, Guimaraes AR, Vangel MG et al. Clinical impact of PET/MR imaging in patients with cancer undergoing sameday PET/CT: initial experience in 134 patients - a hypothesis-generating exploratory study. Radiology 2013;269:857-69.
23. Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A et al. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues. Eur J Radiol 2014;83:289-96.